EpiEMS
Forum Deputy Chief
- 3,845
- 1,164
- 113
I think I'm right there with you on this one, @EpiEMS.
Comparing stats from ROSC studies, trials, therapies or what have you to those of a disease process that can start off with proper prehospital treatment and EGDT prior to even walking through the ED, is very much similar to how AMI/ ACS and CVA patients have IMO proved our worth as field clinicians.
Making prehospital providers part of a "code sepsis", or bundle even if it's merely standard shock therapy treatment (high flow O2, and bilateral large bore access, and IVF), can cut down on admission time.
If we can prove our competency with this as we have with other disease processes this cuts down on the workload of the ED staff, and once more proves our value as a crucial link in the chain of early detection, and prevention.
While I don't think anyone here has, or will dispute this, it's just that comparing the poor outcomes most ROSC patients will have vs. that of even a properly identified SIRS patient is like comparing apples and oranges.
Spot on, I think -- I bring up ROSC as I tend to think we focus a lot of our efforts on a smaller population, particularly one where we can't do all that much. I think triage is a main function of EMS, and that's where we prove our value - identify the disease process, start basic measures, and go from there. I like aligning EMS sepsis therapy to the same framework as ACS and CVA -- it makes good sense given the similarities in terms of progression from entry into the health care system (ED to ICU/CCU, say) through (hopefully) discharge.